This is a preprint.
African origin haplotype protective for Alzheimer's disease in APOE ε4 carriers: exploring potential mechanisms
- PMID: 39484566
- PMCID: PMC11527192
- DOI: 10.1101/2024.10.24.619909
African origin haplotype protective for Alzheimer's disease in APOE ε4 carriers: exploring potential mechanisms
Update in
-
Exploring potential mechanisms of an African protective locus for Alzheimer's disease in APOEε4 carriers.Alzheimers Dement. 2025 Jul;21(7):e70500. doi: 10.1002/alz.70500. Alzheimers Dement. 2025. PMID: 40704449 Free PMC article.
Abstract
APOEε4 is the strongest genetic risk factor for Alzheimer's disease (AD) with approximately 50% of AD patients carrying at least one APOEε4 allele. Our group identified a protective interaction between APOEε4 with the African-specific A allele of rs10423769, which reduces the AD risk effect of APOEε4 homozygotes by approximately 75%. The protective variant lies 2Mb from APOE in a region of segmental duplications (SD) of chromosome 19 containing a cluster of pregnancy specific beta-1 glycoprotein genes (PSGs) and a long non-coding RNA. Using both short and long read sequencing, we demonstrate that rs10423769_A allele lies within a unique single haplotype inside this region of segmental duplication. We identified the protective haplotype in all African ancestry populations studied, including both West and East Africans, suggesting the variant has an old origin. Long-read sequencing identified both structural and DNA methylation differences between the protective rs10423769_A allele and non-protective haplotypes. An expanded variable number tandem repeat (VNTR) containing multiple MEF2 family transcription factor binding motifs was found associated with the protective haplotype (p-value = 2.9e-10). These findings provide novel insights into the mechanisms of this African-origin protective variant for AD in APOEε4 carriers and supports the importance of including all ancestries in AD research.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Figures







References
-
- Rajabli F., Feliciano B.E., Celis K., Hamilton-Nelson K.L., Whitehead P.L., Adams L.D., Bussies P.L., Manrique C P., Rodriguez A., Rodriguez V., et al. (2018). Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations. PLoS Genet 14, 1–13. 10.1371/journal.pgen.1007791. - DOI - PMC - PubMed
-
- Rajabli F., Beecham G.W., Hendrie H.C., Baiyewu O., Ogunniyi A., Gao S., Kushch N.A., Lipkin-Vasquez M., Hamilton-Nelson K.L., Young J.I., et al. (2022). A locus at 19q13.31 significantly reduces the ApoE ε4 risk for Alzheimer’s Disease in African Ancestry. PLoS Genet 18, e1009977. 10.1371/journal.pgen.1009977. - DOI - PMC - PubMed
-
- Chang C.L., Semyonov J., Cheng P.J., Huang S.Y., Park J. Il, Tsai H.-J., Lin C.-Y., Grützner F., Soong Y.K., Cai J.J., et al. (2013). Widespread Divergence of the CEACAM/PSG Genes in Vertebrates and Humans Suggests Sensitivity to Selection. PLoS One 8, e61701. 10.1371/journal.pone.0061701. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous